蛋白酶激活受体4反应性降低的小鼠表现出静脉血栓形成减少和血小板促凝血活性降低
该研究利用携带PAR4-P322L同源突变的小鼠,在下腔静脉淤滞和狭窄模型中观察静脉血栓形成,并通过旋转血栓弹力测定、富血小板血浆凝血酶生成检测及流式细胞术分析血小板促凝血活性。结果显示,杂合或纯合突变小鼠48小时静脉血栓体积减小,血小板磷脂酰丝氨酸暴露、凝血酶生成及血小板-中性粒细胞聚集均降低,为rs2227376降低静脉血栓栓塞风险的关联提供了机制解释。
要点
- PAR4-P322L杂合或纯合小鼠48小时静脉血栓体积减小。
- 突变血小板对凝血酶和响尾蛇毒蛋白的磷脂酰丝氨酸暴露进行性降低。
- 突变血小板凝血酶生成及PAR4介导的血小板-中性粒细胞聚集降低。
核心结论
- 细胞外环3的亮氨酸等位基因PAR4-322L导致促凝血血小板减少、内源性凝血酶潜能降低及血小板-中性粒细胞聚集减少,为PAR4在静脉血栓栓塞中的作用提供了机制。
研究设计与样本
- 使用新近构建的PAR4-P322L小鼠,在下腔静脉淤滞和狭窄模型中检查静脉血栓形成。
- 采用旋转血栓弹力测定凝血和血凝块稳定性,在富血小板血浆中测定凝血酶生成潜能。
- 使用流式细胞术分析磷脂酰丝氨酸表面表达和血小板-中性粒细胞聚集体。
主要发现
- 第310位点杂合(PAR4P/L)或纯合(PAR4L/L)小鼠48小时静脉血栓体积减小。
- PAR4P/L和PAR4L/L血小板对凝血酶和响尾蛇毒蛋白的磷脂酰丝氨酸暴露进行性降低。
- PAR4P/L和PAR4L/L血小板凝血酶生成降低,PAR4介导的血小板-中性粒细胞聚集降低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hypercoagulation and thrombin generation are major risk factors for venous thrombosis. Sustained thrombin signaling through protease-activated receptor (PAR) 4 promotes platelet activation, phosphatidylserine exposure, and subsequent thrombin generation. A single nucleotide polymorphism in PAR4 (rs2227376) changes proline to leucine extracellular loop 3, which decreases PAR4 reactivity and is associated with a lower risk for venous thromboembolism (VTE) in a genome wide association studies meta-analysis. OBJECTIVES: The goal of this study was to determine the mechanism for the association of rs2227376 with a reduced risk of VTE using mice with a homologous mutation (PAR4-P322L). METHODS: Venous thrombosis was examined using our recently generated PAR4-P322L mice in the inferior vena cava stasis and stenosis models. Coagulation and clot stability were measured using rotational thromboelastometry. Thrombin-generating potential was measured in platelet-rich plasma. Phosphatidylserine surface expression and platelet-neutrophil aggregates were analyzed using flow cytometry. RESULTS: Mice heterozygous (PAR4P/L) or homozygous (PAR4L/L) at position 310 had reduced sizes of venous clots at 48 hours. PAR4P/L and PAR4L/L platelets had progressively decreased phosphatidylserine in response to thrombin and convulxin, in addition to decreased thrombin generation and decreased PAR4-mediated platelet-neutrophil aggregation. CONCLUSION: The leucine allele in extracellular loop 3, PAR4-322L, leads to fewer procoagulant platelets, decreased endogenous thrombin potential, and reduced platelet-neutrophil aggregation. This decreased ability to generate thrombin and bind to neutrophils offers a mechanism for PAR4's role in VTE, highlighting a key role for PAR4 signaling.
引用
- Knauss EA, Guci J, Luc N, et al. Mice with reduced protease-activated receptor 4 reactivity show decreased venous thrombosis and platelet procoagulant activity. J Thromb Haemost. 2025. PMID: 39798922. doi:10.1016/j.jtha.2024.12.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。